Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

3D test for diagnosing malignant melanoma

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Sustainable Pharma Manufacturing and Green Facilities

Comprehensive analysis of the environmental strategies being adopted by the pharmaceutical industry to reduce its global footprint. The focus is on integrating energy-efficient technologies, minimizing waste, and ensuring that green facility design becomes a core component of long-term ESG compliance.

Medical Device Manufacturing Powered by Automation...

Examination of the technological shift toward robotics and precision engineering in the medical technology sector. The industry is currently prioritizing the integration of smart manufacturing systems to enhance quality control, reduce human error, and achieve the scalability required for modern healthcare demands.

Advanced Diagnostics Transform Laboratory Management Trends

In-depth analysis of the digital and automated systems revolutionizing clinical laboratory operations. The focus is on how advanced diagnostic tools are enhancing clinical accuracy and operational efficiency while maintaining the highest standards of pathology and patient safety.

UK scientists have developed a 3D test for malignant melanoma that can identify problems not easily spotted in a standard two-dimensional view of the pattern on the skin. The researchers describe the technique in detail in the latest issue of the International Journal of Modelling, Identification and Control.

Malignant melanoma is one of the most aggressive and life-threatening skin cancers. During the last thirty years, incidence rates have increased more than any other cancers in the UK. Successful treatment relies on early diagnosis, so developing an automated scanning method that avoids the need to take biopsies is high on the research agenda.

Conventionally, a group of 2D skin measurements, the asymmetry, border, colour and diameter (ABCD) rules are commonly used to distinguish between malignancy and benign skin growths, but diagnostic accuracy is not convincing.

Now, Lyndon Smith and colleagues at the Machine Vision Laboratory, Bristol Institute of Technology, University of the West of England, Bristol have collaborated with Robert Warr of the Department of Plastic Surgery, at North Bristol NHS Trust, to develop a computer-assisted diagnosis system that could improve outcomes significantly. The system could quickly and automatically reveal changes in the 3D surface texture of skin that occur in malignant melanoma, which are much greater than in benign lesions, such as moles and freckles.

The team used a handheld six-light stereo device connected to a laptop computer to scan the skin’s surface. This device produces a 3D model of the skin texture patterns. The information is then analysed by the laptop, which compares it with patterns recorded from known cases of melanoma, used to "train" the software.

Preliminary studies on a sample set including 12 malignant melanomas and 34 benign lesions have given 91.7% sensitivity and 76.4% specificity from analysis of the 3D skin surface normals, the team says, which is more accurate than the results obtained from 2D pattern recognition.

Diagnosing malignant melanoma accurately is a very difficult task, the researchers say. However, based on these results a simple and non-invasive 3D test could improve the accuracy of diagnosis and so save lives but also avoid unnecessary surgery and treatment in people with benign conditions.

MEDICAL FAIR ASIA 2026

Latest stories

Related stories

Sustainable Pharma Manufacturing and Green Facilities

Comprehensive analysis of the environmental strategies being adopted by the pharmaceutical industry to reduce its global footprint. The focus is on integrating energy-efficient technologies, minimizing waste, and ensuring that green facility design becomes a core component of long-term ESG compliance.

Medical Device Manufacturing Powered by Automation Trends

Examination of the technological shift toward robotics and precision engineering in the medical technology sector. The industry is currently prioritizing the integration of smart manufacturing systems to enhance quality control, reduce human error, and achieve the scalability required for modern healthcare demands.

Advanced Diagnostics Transform Laboratory Management Trends

In-depth analysis of the digital and automated systems revolutionizing clinical laboratory operations. The focus is on how advanced diagnostic tools are enhancing clinical accuracy and operational efficiency while maintaining the highest standards of pathology and patient safety.

Managing Risk and Compliance in Pharma Supply Chains

Comprehensive review of the strategies used to safeguard the pharmaceutical distribution network against modern threats. The focus is on implementing advanced traceability, ensuring cold chain integrity, and maintaining rigorous alignment with global regulatory standards to protect patient safety.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »